CMChinaMNC

Published by ChinaMNC · Hanshan

China's Chronic Disease Reform: A Practical Guide for Foreign Founders on Healthcare Innovation

Foreign founders can learn from China's shift from treatment to health management in Anhui's Suixi County, a model that may inspire healthcare ventures and inform employee health strategies for companies operating in China.

China's Chronic Disease Reform: A Practical Guide for Foreign Founders on Healthcare Innovation

For foreign founders establishing or operating a company in China, understanding the country's evolving healthcare landscape is essential—both for managing employee health benefits and for spotting opportunities in the healthcare sector. A recent government report from Suixi County in Anhui Province illustrates China's shift from reactive treatment to proactive health management, offering a valuable case study.

The Shift to Proactive Health Management

In Suixi County, family doctors like Chen Shumin conduct regular home visits to patients with chronic conditions such as diabetes and hypertension. Chen, a village clinic doctor in Daokou Village, Baishan Town, visits key patients at least once per quarter. She also participates in WeChat groups that include doctors from the town health center and the county people's hospital, allowing villagers to consult with medical professionals at any time. This approach stems from Suixi's "1+1+1" family doctor contract service, which teams up county-level, town-level, and village-level doctors to provide health management for all residents.

Wu Liang, director of the Suixi County Health Commission, explained that the county is pushing medical institutions to transition from "treatment-centered" to "health management-centered" by changing incentive mechanisms and improving chronic disease management at grassroots facilities. During the "14th Five-Year Plan" period, the average annual hospitalization cost per insured person within the county dropped from 8,509 yuan to 6,586 yuan, and the premature mortality rate for four major chronic diseases fell from 13.74% to 11.07%.

Institutional Reforms Driving Results

These figures are backed by a comprehensive institutional framework. Suixi has consolidated all medical units into two medical communities led by county-level public hospitals. Within these communities, a "lump-sum" payment system is implemented: after deducting risk reserves and critical illness insurance funds, at least 95% of the total premium for covered residents is allocated to the medical community to manage. If annual medical insurance funds generate a surplus, it is distributed among county, town, and village institutions in a 6:3:1 ratio, primarily for staff salaries and performance bonuses.

Chen Zhuo, head of the Suixi Medical Reform Office, noted that the less illness among insured residents and the lower the costs, the higher the income for hospitals and doctors. This incentivizes medical institutions to manage health effectively, and lead hospitals are more willing to help town and village facilities improve their capabilities.

Additionally, Suixi has assigned funds for 47 common chronic disease groups to town health centers based on a per-capita quota, with surpluses retained by county, town, and village institutions in a 4:4:2 ratio. Chen explained that chronic diseases require long-term management, and past assessments focused only on single treatments or hospitalizations, unable to gauge ongoing management quality. Per-capita management encourages medical staff to strengthen contract signing, follow-ups, and medication guidance, leading to better chronic disease control.

Surpluses have also improved medical staff compensation. Suixi's medical insurance fund has achieved surpluses for nine consecutive years, and the chronic disease insurance fund for five consecutive years.

Digital Integration and Data-Driven Management

Suixi has integrated health records for chronic disease patients and built a tiered online management system, currently covering 131,000 chronic disease patients in the county. In 2025, the pilot chronic disease population increased by 4,152 year-on-year to nearly 150,000. Total medical costs for this group were 255.414 million yuan, down 0.18% year-on-year, and total hospitalization costs were 192.5575 million yuan, down 4.07% year-on-year.

Implications for Foreign Founders

For foreign founders, this reform signals China's commitment to improving healthcare efficiency and controlling costs—factors that can affect employee health insurance and overall operational expenses. Moreover, the emphasis on digital health management and incentive-driven care models may open doors for innovative healthcare startups.

When establishing a company in China, foreign founders should consider how local healthcare policies may impact their workforce and explore potential partnerships in the growing health management sector. Understanding these reforms can also help in designing employee wellness programs that align with China's proactive health approach.

This summary is based on information published by the relevant Chinese government website and is general information, not legal or tax advice.

Call to Action: Foreign founders can contact ChinaMNC on WhatsApp / WeChat at +86 153 1898 8535 for help registering and operating a company in China.

Talk to us

WhatsApp / WeChat: +86 153 1898 8535

General information only, not legal or tax advice.